Measurement of fatigue - Determining minimally important clinical differences

Journal of Clinical Epidemiology

Volumn 55, Issue 3, 2002, Pages 239-244

  Schwartz, Anna L ^a   Meek, Paula M ^b   Nail, Lillian M ^a   Fargo, James ^c   Lundquist, Margaret ^c   Donofrio, Melissa ^d   Grainger, Marilyn ^e   Throckmorton, Terry ^f   Mateo, Magdalena ^g  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d Duluth Clinic   (United States)

^e Waukesha Memorial Hospital   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Fatigue; Measurement; Minimally important clinical difference

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SYMPTOM;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 0036187390     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(01)00469-3     Document Type: Article

References (27)

1. A critical appraisal of the research literature investigating fatigue in cancer patients
2. 1994 Oncology nursing society research priorities survey
3. Measurement of health status: Ascertaining the minimal clinically important difference
4. Assessing the minimal important difference in symptoms: A comparison of two techniques
5. Statistical significance versus clinical relevance. Part I. The essential role of the power of a statistical test
6. Determining a minimally important change in a disease-specific quality of life questionnaire
7. A measure of quality of life for clinical trials in chronic lung disease
8. Proceedings of the international conference on the measurement of quality of life as an outcome in clinical trials
9. Assessing the clinical importance of symptomatic improvements
10. Indexes and boundaries for "qualitative significance" in statistical decisions
11. Methodological problems in the retrospective computation of responsiveness to change: The lesson of Chronhach
12. Measuring fatigue
13. The need for evidence-based medicine
14. Internal consistency reliability and construct validity of a new measure of cancer treatment related fatigue: The General Fatigue Scale (GFS)
15. Additional construct validity of the Schwartz Cancer Fatigue Scale
16. Process of coping with radiation therapy
17. Psychometric testing of fatigue instruments for use with cancer patients
18. Reliability and validity of the Schwartz Cancer Fatigue Scale
19. Basic statistics for clinicians: 3. Assessing the effects of treatment: Measures of association
20. Development and testing of a new measure of health status for clinical trials in heart failure
21. Measuring quality of life in asthma
22. The minimal important difference: Who's to say what is important?
23. Effect of salmeterol on asthma quality of life
24. Fatigue patterns observed in patients receiving chemotherapy and radiotherapy
25. Users' guides to the medical literature: XXV. Evidence-based medicine: Principles for applying the users' guides to patient care. Evidence-based medicine working group